MILESTONE PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, July 3, 2019, a trademark application was filed for MILESTONE PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the MILESTONE PHARMACEUTICALS trademark a serial number of 88499919. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, October 2, 2024. This trademark is owned by Milestone Pharmaceuticals USA, Inc.. The MILESTONE PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Cardiovascular treatment preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, intranasally administered medications, and pharmaceutical preparations for the treatment of cardiovascular disorders; Cardiovascular pharmaceuticals
milestone pharmaceuticals

General Information

Serial Number88499919
Word MarkMILESTONE PHARMACEUTICALS
Filing DateWednesday, July 3, 2019
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, October 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements

Goods and ServicesCardiovascular treatment preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, intranasally administered medications, and pharmaceutical preparations for the treatment of cardiovascular disorders; Cardiovascular pharmaceuticals
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMilestone Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCharlotte, NC 28277
Party NameMilestone Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCharlotte, NC 28277

Trademark Events

Event DateEvent Description
Tuesday, September 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, July 6, 2019NEW APPLICATION ENTERED
Saturday, July 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, September 22, 2019ASSIGNED TO EXAMINER
Tuesday, September 24, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 24, 2019NON-FINAL ACTION E-MAILED
Tuesday, March 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 1, 2020SUSPENSION LETTER WRITTEN
Wednesday, April 1, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, April 1, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 1, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 1, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 1, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, April 3, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, October 2, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, April 2, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 3, 2024SOU EXTENSION 1 GRANTED
Wednesday, January 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 3, 2024SOU EXTENSION 1 FILED
Wednesday, October 2, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2024SOU EXTENSION 2 FILED
Wednesday, October 2, 2024SOU EXTENSION 2 GRANTED
Friday, January 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

pharmaceuticals milestone cardiovascular preparations prescription treatment administered intranasally medications disorders sachets